Gerald Clarke | 09/18/2013
Is part of the problem in the lack of correlation between in vivo reults to in vitro results a poor choice of cell models? We spoke to Sandi Engle Senior Principal Scientist at Pfizer Global Research about the promise held by using stem cell derived cells as models for human disease.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More